Somatropin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00052 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | middle ear neuroendocrine tumor | KG + DL |
| 2 | malignant cutaneous granular cell skin tumor | KG + DL |
| 3 | ectomesenchymoma | KG + DL |
| 4 | human herpesvirus 8-related tumor | KG + DL |
| 5 | mixed gonadal dysgenesis | KG + DL |
| 6 | mosaic monosomy X | KG + DL |
| 7 | Turner syndrome due to structural X chromosome anomalies | KG + DL |
| 8 | familial generalized lentiginosis | KG + DL |
| 9 | rhabdoid tumor | KG + DL |
| 10 | gastrocutaneous syndrome | KG + DL |
| 11 | X chromosome number anomaly | KG + DL |
| 12 | sex chromosome disorder of sex development | KG + DL |
| 13 | Moynahan syndrome | KG + DL |
| 14 | acromelanosis | KG + DL |
| 15 | congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | KG + DL |
| 16 | leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | KG + DL |
| 17 | osteopathia striata-pigmentary dermopathy-white forelock syndrome | KG + DL |
| 18 | sterol biosynthesis disorder | KG + DL |
| 19 | peripheral nerve schwannoma | KG + DL |
| 20 | schwannoma of twelfth cranial nerve | KG + DL |
| 21 | microcystic/reticular schwannoma | KG + DL |
| 22 | trigeminal schwannoma | KG + DL |
| 23 | sympathetic neurilemmoma | KG + DL |
| 24 | Steel syndrome | KG + DL |
| 25 | hypophosphatasia | KG + DL |
| 26 | reticular dysgenesis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.